Loading…

The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer

Destruction of cancer cells by cytotoxic T lymphocytes depends on immunogenic tumor peptides generated by proteasomes and presented by human leukocyte antigen (HLA) molecules. Functional differences arising from alleles of immunoproteasome subunits have not been recognized so far. We analyzed the ge...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2011-12, Vol.71 (23), p.7145-7154
Main Authors: FELLERHOFF, Barbara, SONGHAI GU, LAUMBACHER, Barbara, NERLICH, Andreas G, WEISS, Elisabeth H, GLAS, Jürgen, KOPP, Reinhard, JOHNSON, Judith P, WANK, Rudolf
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33
cites cdi_FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33
container_end_page 7154
container_issue 23
container_start_page 7145
container_title Cancer research (Chicago, Ill.)
container_volume 71
creator FELLERHOFF, Barbara
SONGHAI GU
LAUMBACHER, Barbara
NERLICH, Andreas G
WEISS, Elisabeth H
GLAS, Jürgen
KOPP, Reinhard
JOHNSON, Judith P
WANK, Rudolf
description Destruction of cancer cells by cytotoxic T lymphocytes depends on immunogenic tumor peptides generated by proteasomes and presented by human leukocyte antigen (HLA) molecules. Functional differences arising from alleles of immunoproteasome subunits have not been recognized so far. We analyzed the genetic polymorphism of the immunoproteasome subunits LMP2 and LMP7 and of the transporters associated with antigen processing (TAP1 and TAP2) in two independently collected panels of colorectal carcinoma patients (N(1) = 112, N(2) = 62; controls, N = 165). High risk of colon cancer was associated with the LMP7-K/Q genotype (OR = 8.10, P = 1.10 × 10(-11)) and low risk with the LMP7-Q/Q genotype (OR = 0.10, P = 5.97 × 10(-13)). The basis for these distinct associations of LMP7 genotypes was functionally assessed by IFN-γ stimulation of colon carcinoma cell lines (N = 10), followed by analyses of mRNA expression of HLA class I, TAP1, TAP2, and LMP7, with real-time PCR. Whereas induction of HLA-B, TAP1, and TAP2 was comparable in all cell lines, transcript amounts of LMP7-Q increased 10-fold, but of LMP7-K only 3.8-fold. This correlated with a reduced transcript stability of LMP7-K (t(1/2) ≈ 7 minutes) compared with LMP7-Q (t(1/2) ≈ 33 minutes). In addition, LMP7-Q/Q colon carcinoma cells increased (the peptide based) HLA class I surface expression significantly after IFN-γ stimulation, whereas LMP7-Q/K and LMP7-K/K carcinoma cells showed minimal (
doi_str_mv 10.1158/0008-5472.CAN-10-1883
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_908001498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1753466955</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxa0KRJeWj1DkC4JLiv_bOa6i0lZdaFWWc-Q4E9bgJIudoPbb19tuy43TaEa_eaN5D6ETSk4pleYzIcQUUmh2Wi2_FZQU1Bh-gBZUclNoIeQrtHhhDtHblH7lVlIi36BDxgjXRpMF-rveAF59vdHFFV6GAAHw2OEpDy_7fh7GbRwnsGnsAZ_dbXzjp4RvoZ0dtHgd7ZBc9NsJf59s44Of7rEdWnwTofUukxf-5wbf-vR7J1qNYRxwZQcH8Ri97mxI8G5fj9CPL2fr6qJYXZ9fVstV4QQ1U9G0wBrbdVSUVCvCGXXWMKGEsaUVnFAgmmlgraNlI5hSTDJwRitFSac6zo_Qxyfd_MefGdJU9z45CMEOMM6pLokhJKubTH76L0m15EKpUsqMyifUxTGlCF29jb638b6mpN6FU--Mr3fG1zmcx2kOJ--935-Ymx7al63nNDLwYQ_Y5Gzosr_Op3-cZJIIzfkDpcGV3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1753466955</pqid></control><display><type>article</type><title>The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer</title><source>EZB Electronic Journals Library</source><creator>FELLERHOFF, Barbara ; SONGHAI GU ; LAUMBACHER, Barbara ; NERLICH, Andreas G ; WEISS, Elisabeth H ; GLAS, Jürgen ; KOPP, Reinhard ; JOHNSON, Judith P ; WANK, Rudolf</creator><creatorcontrib>FELLERHOFF, Barbara ; SONGHAI GU ; LAUMBACHER, Barbara ; NERLICH, Andreas G ; WEISS, Elisabeth H ; GLAS, Jürgen ; KOPP, Reinhard ; JOHNSON, Judith P ; WANK, Rudolf</creatorcontrib><description>Destruction of cancer cells by cytotoxic T lymphocytes depends on immunogenic tumor peptides generated by proteasomes and presented by human leukocyte antigen (HLA) molecules. Functional differences arising from alleles of immunoproteasome subunits have not been recognized so far. We analyzed the genetic polymorphism of the immunoproteasome subunits LMP2 and LMP7 and of the transporters associated with antigen processing (TAP1 and TAP2) in two independently collected panels of colorectal carcinoma patients (N(1) = 112, N(2) = 62; controls, N = 165). High risk of colon cancer was associated with the LMP7-K/Q genotype (OR = 8.10, P = 1.10 × 10(-11)) and low risk with the LMP7-Q/Q genotype (OR = 0.10, P = 5.97 × 10(-13)). The basis for these distinct associations of LMP7 genotypes was functionally assessed by IFN-γ stimulation of colon carcinoma cell lines (N = 10), followed by analyses of mRNA expression of HLA class I, TAP1, TAP2, and LMP7, with real-time PCR. Whereas induction of HLA-B, TAP1, and TAP2 was comparable in all cell lines, transcript amounts of LMP7-Q increased 10-fold, but of LMP7-K only 3.8-fold. This correlated with a reduced transcript stability of LMP7-K (t(1/2) ≈ 7 minutes) compared with LMP7-Q (t(1/2) ≈ 33 minutes). In addition, LMP7-Q/Q colon carcinoma cells increased (the peptide based) HLA class I surface expression significantly after IFN-γ stimulation, whereas LMP7-Q/K and LMP7-K/K carcinoma cells showed minimal (&lt;20%) changes. These results suggest that the presence of LMP7-K can reduce the formation of immunoproteasomes and thus peptide processing, followed by reduced peptide-HLA presentation, a crucial factor in the immune response against cancer.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-10-1883</identifier><identifier>PMID: 22037870</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adult ; Aged ; Alleles ; Antineoplastic agents ; ATP-Binding Cassette Sub-Family B Member 2 ; ATP-Binding Cassette Transporters - genetics ; ATP-Binding Cassette Transporters - immunology ; ATP-Binding Cassette, Sub-Family B, Member 3 ; Biological and medical sciences ; Caco-2 Cells ; Cell Line, Tumor ; Colonic Neoplasms - genetics ; Colonic Neoplasms - immunology ; Colonic Neoplasms - pathology ; Colorectal Neoplasms - genetics ; Colorectal Neoplasms - immunology ; Colorectal Neoplasms - metabolism ; Cysteine Endopeptidases - genetics ; Cysteine Endopeptidases - immunology ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Gene Expression Regulation, Neoplastic - immunology ; Gene Frequency - immunology ; Genes, MHC Class I - genetics ; Genes, MHC Class I - immunology ; Genetic Predisposition to Disease ; Genotype ; HeLa Cells ; HLA-B Antigens - genetics ; HLA-B Antigens - immunology ; HT29 Cells ; Humans ; Immunogenetics - methods ; Interferon-gamma - genetics ; Interferon-gamma - immunology ; Interferon-gamma - metabolism ; Male ; Medical sciences ; Pharmacology. Drug treatments ; Polymorphism, Genetic ; Proteasome Endopeptidase Complex - genetics ; Proteasome Endopeptidase Complex - immunology ; RNA, Messenger - genetics ; RNA, Messenger - immunology ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2011-12, Vol.71 (23), p.7145-7154</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33</citedby><cites>FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25250473$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22037870$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FELLERHOFF, Barbara</creatorcontrib><creatorcontrib>SONGHAI GU</creatorcontrib><creatorcontrib>LAUMBACHER, Barbara</creatorcontrib><creatorcontrib>NERLICH, Andreas G</creatorcontrib><creatorcontrib>WEISS, Elisabeth H</creatorcontrib><creatorcontrib>GLAS, Jürgen</creatorcontrib><creatorcontrib>KOPP, Reinhard</creatorcontrib><creatorcontrib>JOHNSON, Judith P</creatorcontrib><creatorcontrib>WANK, Rudolf</creatorcontrib><title>The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Destruction of cancer cells by cytotoxic T lymphocytes depends on immunogenic tumor peptides generated by proteasomes and presented by human leukocyte antigen (HLA) molecules. Functional differences arising from alleles of immunoproteasome subunits have not been recognized so far. We analyzed the genetic polymorphism of the immunoproteasome subunits LMP2 and LMP7 and of the transporters associated with antigen processing (TAP1 and TAP2) in two independently collected panels of colorectal carcinoma patients (N(1) = 112, N(2) = 62; controls, N = 165). High risk of colon cancer was associated with the LMP7-K/Q genotype (OR = 8.10, P = 1.10 × 10(-11)) and low risk with the LMP7-Q/Q genotype (OR = 0.10, P = 5.97 × 10(-13)). The basis for these distinct associations of LMP7 genotypes was functionally assessed by IFN-γ stimulation of colon carcinoma cell lines (N = 10), followed by analyses of mRNA expression of HLA class I, TAP1, TAP2, and LMP7, with real-time PCR. Whereas induction of HLA-B, TAP1, and TAP2 was comparable in all cell lines, transcript amounts of LMP7-Q increased 10-fold, but of LMP7-K only 3.8-fold. This correlated with a reduced transcript stability of LMP7-K (t(1/2) ≈ 7 minutes) compared with LMP7-Q (t(1/2) ≈ 33 minutes). In addition, LMP7-Q/Q colon carcinoma cells increased (the peptide based) HLA class I surface expression significantly after IFN-γ stimulation, whereas LMP7-Q/K and LMP7-K/K carcinoma cells showed minimal (&lt;20%) changes. These results suggest that the presence of LMP7-K can reduce the formation of immunoproteasomes and thus peptide processing, followed by reduced peptide-HLA presentation, a crucial factor in the immune response against cancer.</description><subject>Adult</subject><subject>Aged</subject><subject>Alleles</subject><subject>Antineoplastic agents</subject><subject>ATP-Binding Cassette Sub-Family B Member 2</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>ATP-Binding Cassette Transporters - immunology</subject><subject>ATP-Binding Cassette, Sub-Family B, Member 3</subject><subject>Biological and medical sciences</subject><subject>Caco-2 Cells</subject><subject>Cell Line, Tumor</subject><subject>Colonic Neoplasms - genetics</subject><subject>Colonic Neoplasms - immunology</subject><subject>Colonic Neoplasms - pathology</subject><subject>Colorectal Neoplasms - genetics</subject><subject>Colorectal Neoplasms - immunology</subject><subject>Colorectal Neoplasms - metabolism</subject><subject>Cysteine Endopeptidases - genetics</subject><subject>Cysteine Endopeptidases - immunology</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Gene Expression Regulation, Neoplastic - immunology</subject><subject>Gene Frequency - immunology</subject><subject>Genes, MHC Class I - genetics</subject><subject>Genes, MHC Class I - immunology</subject><subject>Genetic Predisposition to Disease</subject><subject>Genotype</subject><subject>HeLa Cells</subject><subject>HLA-B Antigens - genetics</subject><subject>HLA-B Antigens - immunology</subject><subject>HT29 Cells</subject><subject>Humans</subject><subject>Immunogenetics - methods</subject><subject>Interferon-gamma - genetics</subject><subject>Interferon-gamma - immunology</subject><subject>Interferon-gamma - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymorphism, Genetic</subject><subject>Proteasome Endopeptidase Complex - genetics</subject><subject>Proteasome Endopeptidase Complex - immunology</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - immunology</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kU9v1DAQxa0KRJeWj1DkC4JLiv_bOa6i0lZdaFWWc-Q4E9bgJIudoPbb19tuy43TaEa_eaN5D6ETSk4pleYzIcQUUmh2Wi2_FZQU1Bh-gBZUclNoIeQrtHhhDtHblH7lVlIi36BDxgjXRpMF-rveAF59vdHFFV6GAAHw2OEpDy_7fh7GbRwnsGnsAZ_dbXzjp4RvoZ0dtHgd7ZBc9NsJf59s44Of7rEdWnwTofUukxf-5wbf-vR7J1qNYRxwZQcH8Ri97mxI8G5fj9CPL2fr6qJYXZ9fVstV4QQ1U9G0wBrbdVSUVCvCGXXWMKGEsaUVnFAgmmlgraNlI5hSTDJwRitFSac6zo_Qxyfd_MefGdJU9z45CMEOMM6pLokhJKubTH76L0m15EKpUsqMyifUxTGlCF29jb638b6mpN6FU--Mr3fG1zmcx2kOJ--935-Ymx7al63nNDLwYQ_Y5Gzosr_Op3-cZJIIzfkDpcGV3Q</recordid><startdate>20111201</startdate><enddate>20111201</enddate><creator>FELLERHOFF, Barbara</creator><creator>SONGHAI GU</creator><creator>LAUMBACHER, Barbara</creator><creator>NERLICH, Andreas G</creator><creator>WEISS, Elisabeth H</creator><creator>GLAS, Jürgen</creator><creator>KOPP, Reinhard</creator><creator>JOHNSON, Judith P</creator><creator>WANK, Rudolf</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20111201</creationdate><title>The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer</title><author>FELLERHOFF, Barbara ; SONGHAI GU ; LAUMBACHER, Barbara ; NERLICH, Andreas G ; WEISS, Elisabeth H ; GLAS, Jürgen ; KOPP, Reinhard ; JOHNSON, Judith P ; WANK, Rudolf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Alleles</topic><topic>Antineoplastic agents</topic><topic>ATP-Binding Cassette Sub-Family B Member 2</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>ATP-Binding Cassette Transporters - immunology</topic><topic>ATP-Binding Cassette, Sub-Family B, Member 3</topic><topic>Biological and medical sciences</topic><topic>Caco-2 Cells</topic><topic>Cell Line, Tumor</topic><topic>Colonic Neoplasms - genetics</topic><topic>Colonic Neoplasms - immunology</topic><topic>Colonic Neoplasms - pathology</topic><topic>Colorectal Neoplasms - genetics</topic><topic>Colorectal Neoplasms - immunology</topic><topic>Colorectal Neoplasms - metabolism</topic><topic>Cysteine Endopeptidases - genetics</topic><topic>Cysteine Endopeptidases - immunology</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Gene Expression Regulation, Neoplastic - immunology</topic><topic>Gene Frequency - immunology</topic><topic>Genes, MHC Class I - genetics</topic><topic>Genes, MHC Class I - immunology</topic><topic>Genetic Predisposition to Disease</topic><topic>Genotype</topic><topic>HeLa Cells</topic><topic>HLA-B Antigens - genetics</topic><topic>HLA-B Antigens - immunology</topic><topic>HT29 Cells</topic><topic>Humans</topic><topic>Immunogenetics - methods</topic><topic>Interferon-gamma - genetics</topic><topic>Interferon-gamma - immunology</topic><topic>Interferon-gamma - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymorphism, Genetic</topic><topic>Proteasome Endopeptidase Complex - genetics</topic><topic>Proteasome Endopeptidase Complex - immunology</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - immunology</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FELLERHOFF, Barbara</creatorcontrib><creatorcontrib>SONGHAI GU</creatorcontrib><creatorcontrib>LAUMBACHER, Barbara</creatorcontrib><creatorcontrib>NERLICH, Andreas G</creatorcontrib><creatorcontrib>WEISS, Elisabeth H</creatorcontrib><creatorcontrib>GLAS, Jürgen</creatorcontrib><creatorcontrib>KOPP, Reinhard</creatorcontrib><creatorcontrib>JOHNSON, Judith P</creatorcontrib><creatorcontrib>WANK, Rudolf</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FELLERHOFF, Barbara</au><au>SONGHAI GU</au><au>LAUMBACHER, Barbara</au><au>NERLICH, Andreas G</au><au>WEISS, Elisabeth H</au><au>GLAS, Jürgen</au><au>KOPP, Reinhard</au><au>JOHNSON, Judith P</au><au>WANK, Rudolf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2011-12-01</date><risdate>2011</risdate><volume>71</volume><issue>23</issue><spage>7145</spage><epage>7154</epage><pages>7145-7154</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Destruction of cancer cells by cytotoxic T lymphocytes depends on immunogenic tumor peptides generated by proteasomes and presented by human leukocyte antigen (HLA) molecules. Functional differences arising from alleles of immunoproteasome subunits have not been recognized so far. We analyzed the genetic polymorphism of the immunoproteasome subunits LMP2 and LMP7 and of the transporters associated with antigen processing (TAP1 and TAP2) in two independently collected panels of colorectal carcinoma patients (N(1) = 112, N(2) = 62; controls, N = 165). High risk of colon cancer was associated with the LMP7-K/Q genotype (OR = 8.10, P = 1.10 × 10(-11)) and low risk with the LMP7-Q/Q genotype (OR = 0.10, P = 5.97 × 10(-13)). The basis for these distinct associations of LMP7 genotypes was functionally assessed by IFN-γ stimulation of colon carcinoma cell lines (N = 10), followed by analyses of mRNA expression of HLA class I, TAP1, TAP2, and LMP7, with real-time PCR. Whereas induction of HLA-B, TAP1, and TAP2 was comparable in all cell lines, transcript amounts of LMP7-Q increased 10-fold, but of LMP7-K only 3.8-fold. This correlated with a reduced transcript stability of LMP7-K (t(1/2) ≈ 7 minutes) compared with LMP7-Q (t(1/2) ≈ 33 minutes). In addition, LMP7-Q/Q colon carcinoma cells increased (the peptide based) HLA class I surface expression significantly after IFN-γ stimulation, whereas LMP7-Q/K and LMP7-K/K carcinoma cells showed minimal (&lt;20%) changes. These results suggest that the presence of LMP7-K can reduce the formation of immunoproteasomes and thus peptide processing, followed by reduced peptide-HLA presentation, a crucial factor in the immune response against cancer.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>22037870</pmid><doi>10.1158/0008-5472.CAN-10-1883</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2011-12, Vol.71 (23), p.7145-7154
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_908001498
source EZB Electronic Journals Library
subjects Adult
Aged
Alleles
Antineoplastic agents
ATP-Binding Cassette Sub-Family B Member 2
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - immunology
ATP-Binding Cassette, Sub-Family B, Member 3
Biological and medical sciences
Caco-2 Cells
Cell Line, Tumor
Colonic Neoplasms - genetics
Colonic Neoplasms - immunology
Colonic Neoplasms - pathology
Colorectal Neoplasms - genetics
Colorectal Neoplasms - immunology
Colorectal Neoplasms - metabolism
Cysteine Endopeptidases - genetics
Cysteine Endopeptidases - immunology
Female
Gastroenterology. Liver. Pancreas. Abdomen
Gene Expression Regulation, Neoplastic - immunology
Gene Frequency - immunology
Genes, MHC Class I - genetics
Genes, MHC Class I - immunology
Genetic Predisposition to Disease
Genotype
HeLa Cells
HLA-B Antigens - genetics
HLA-B Antigens - immunology
HT29 Cells
Humans
Immunogenetics - methods
Interferon-gamma - genetics
Interferon-gamma - immunology
Interferon-gamma - metabolism
Male
Medical sciences
Pharmacology. Drug treatments
Polymorphism, Genetic
Proteasome Endopeptidase Complex - genetics
Proteasome Endopeptidase Complex - immunology
RNA, Messenger - genetics
RNA, Messenger - immunology
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Tumors
title The LMP7-K Allele of the Immunoproteasome Exhibits Reduced Transcript Stability and Predicts High Risk of Colon Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A22%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20LMP7-K%20Allele%20of%20the%20Immunoproteasome%20Exhibits%20Reduced%20Transcript%20Stability%20and%20Predicts%20High%20Risk%20of%20Colon%20Cancer&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=FELLERHOFF,%20Barbara&rft.date=2011-12-01&rft.volume=71&rft.issue=23&rft.spage=7145&rft.epage=7154&rft.pages=7145-7154&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-10-1883&rft_dat=%3Cproquest_cross%3E1753466955%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-bde2baff1491760321ca824648a9a4301e0727e2dc19b4266252ec876610f6f33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1753466955&rft_id=info:pmid/22037870&rfr_iscdi=true